Literature DB >> 19401060

Melanoma.

Daniel G Coit, Robert Andtbacka, Christopher K Bichakjian, Raza A Dilawari, Dominick Dimaio, Valerie Guild, Allan C Halpern, F Stephen Hodi, Mohammed Kashani-Sabet, Julie R Lange, Anne Lind, Lainie Martin, Mary C Martini, Scott K Pruitt, Merrick I Ross, Stephen F Sener, Susan M Swetter, Kenneth K Tanabe, John A Thompson, Vijay Trisal, Marshall M Urist, Jeffrey Weber, Michael K Wong.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19401060     DOI： 10.6004/jnccn.2009.0020

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  35 in total

1.  Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I).

Authors:  J Harrison Howard; John F Thompson; Nicola Mozzillo; Omgo E Nieweg; Harald J Hoekstra; Daniel F Roses; Vernon K Sondak; Douglas S Reintgen; Mohammed Kashani-Sabet; Constantine P Karakousis; Brendon J Coventry; William G Kraybill; B Mark Smithers; Robert Elashoff; Stacey L Stern; Alistair J Cochran; Mark B Faries; Donald L Morton
Journal:  Ann Surg Oncol       Date:  2012-05-31       Impact factor: 5.344

2.  Delayed Reconstruction for the Non-Amputative Treatment of Subungual Melanoma.

Authors:  Byung Ho Oh; Hong Sun Jang; Jungsoo Lee; Min Ju Choi; Kyoung Ae Nam; Kee Yang Chung
Journal:  Ann Dermatol       Date:  2015-07-29       Impact factor: 1.444

Review 3.  Current treatment of locoregional recurrence of melanoma.

Authors:  Malcolm Hart Squires; Keith A Delman
Journal:  Curr Oncol Rep       Date:  2013-10       Impact factor: 5.075

4.  Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines.

Authors:  Emanuela Romano; Michael Scordo; Stephen W Dusza; Daniel G Coit; Paul B Chapman
Journal:  J Clin Oncol       Date:  2010-05-17       Impact factor: 44.544

5.  Mayo Clinic consensus recommendations for the depth of excision in primary cutaneous melanoma.

Authors:  Travis E Grotz; Svetomir N Markovic; Lori A Erickson; William S Harmsen; Marianne Huebner; David R Farley; Barbara A Pockaj; John H Donohue; Franklin H Sim; Clive S Grant; Sanjay P Bagaria; Thomas C Shives; Charles M Balch; James W Jakub
Journal:  Mayo Clin Proc       Date:  2011-06       Impact factor: 7.616

6.  Management of regional lymph node basins in melanoma.

Authors:  Timothy P Love; Keith A Delman
Journal:  Ochsner J       Date:  2010

Review 7.  Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma.

Authors:  Pascale Dequen; Paul Lorigan; Jeroen P Jansen; Marc van Baardewijk; Mario J N M Ouwens; Srividya Kotapati
Journal:  Oncologist       Date:  2012-09-28

8.  Polymer conjugate of a microtubule destabilizer inhibits lung metastatic melanoma.

Authors:  Ruinan Yang; Goutam Mondal; Rachel A Ness; Kinsie Arnst; Vaibhav Mundra; Duane D Miller; Wei Li; Ram I Mahato
Journal:  J Control Release       Date:  2017-01-24       Impact factor: 9.776

9.  Use of imiquimod for residual acral melanoma.

Authors:  Gloria R Sue; Allison Hanlon; Rossitza Lazova; Deepak Narayan
Journal:  BMJ Case Rep       Date:  2014-08-21

10.  Evaluation of (68)Ga- and (177)Lu-DOTA-PEG4-LLP2A for VLA-4-Targeted PET Imaging and Treatment of Metastatic Melanoma.

Authors:  Wissam Beaino; Jessie R Nedrow; Carolyn J Anderson
Journal:  Mol Pharm       Date:  2015-05-08       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.